Familial platelet disorder with predisposition to acute myeloid leukemia (FPD/AML) has been well documented in the literature and is a new entity within the latest revised edition of the WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues (OMIM). The disorder arises due to mutaKeywords Acute myeloid leukemia · Familial platelet disorders · Predisposition to AML syndromes · RUNX1 deletion 
tions within the RUNX1 gene in chromosome 21; mutations within the Runt-binding domain are the most commonly encountered anomalies that cause decreased platelet count and function. Rare cases of haploinsufficiency have also been shown to cause this disorder. Here, we describe a 12-year-old female with mosaicism for a ring chromosome 21 and monosomy 21 who was born with thrombocytopenia which is now explained by loss of the RUNX1 gene resulting in FPD/AML. We also comment on the structure of the ring and the mechanism of its formation. © 2018 S. Karger AG, Basel Recently reported in the literature and in the latest edition of the WHO Classification of Tumors of the Hematopoietic and Lymphoid Tissues, the entity of familial disorders with predisposition to acute myeloid leukemia (AML) has been defined. Within this category, loss of function of a single RUNX1 allele not only predisposes the family members to hematologic neoplasms, but also to platelet dysfunction. Herein, a novel mechanism of RUNX1 deletion is described.
Case Report
A 12-year-old female was referred to the pediatric hematology clinic for management of her thrombocytopenia in advance of pending surgery for severe scoliosis. The patient was born with multiple congenital anomalies including intrauterine growth restriction, microcephaly, cleft lip, a broad nasal tip, low-set ears with overfolded helix, prominent antihelix, proximal thumb insertion, and slightly dorsiflexed great toes. At birth, cytogenetic analysis showed mosaicism for cells with 45,XX,-21 and 46,XX,r(21) (p13q22) with the cell lines present in 40 and 60% of the cells, respectively. She also required platelet transfusions. This patient was the subject of a previous publication shortly after her birth that highlighted the thrombocytopenia and the chromosome anomaly which was investigated only by routine chromosome analysis [Cavan et al., 2009] .
Her platelet counts have varied from 9-80 k/μL, and analysis of her platelet function demonstrates abnormal function with prolonged closure times for collagen/epinephrine and collagen/ADP. At 1 year of age she developed seizures, and since that time her development has been delayed with severe mental disability including mutism, hearing loss, and continuous drooling. At 10 years of age, she required a tooth extraction that resulted in severe bleeding and the need for multiple platelet transfusions. Currently, in addition to developmental delays, the patient suffers from rapid onset scoliosis of the thoracic spine requiring a chest mold, multiple malpositioned teeth with gingivitis, seizures controlled by medication, and easy bruising/bleeding. She is able to walk independently but with an unsteady gait.
Methods and Results
At her recent clinic visit, chromosome and microarray analyses of peripheral blood were ordered. Routine chromosome analysis found that the cells with monosomy 21 and ring chromosome 21 were still present, but an additional clone of 46,XX cells was also observed as well as cells with an isochromosome 21q and rare cells with larger rings ( Fig. 1 a) . Cytological examination of the ring chromosome suggested a double structure, including 2 copies of proximal 21q with loss of distal q, rather than a simple ring. FISH analysis using a probe from band 21q21.1 (Empire Genomics) showed 1 copy on the normal chromosome 21, and 2 copies on the standard ring ( Fig. 1 b) ; in 100 cells scored, a double ring was present in a single cell. Microarray analysis using an Oxford Gene Technology CytoSure Constitutional v3 + LOH 4x180k CGH and SNP array with average resolution of 68 kb for targeted (genes) regions, 74-162 kb for the backbone and LOH of 7-10 Mb and CytoSure Interpret v 4.10.41 software was performed. The analysis demonstrated a full copy deletion of the distal portion of the q arm (q22.11qter) which included the RUNX1 gene at 21q22.1 ( Fig. 2 ) . Distal 21q demonstrated complete homozygosity, while the proximal portion is biallelic (data not shown). Further, the array clearly demonstrates 3 copy levels of sequences of chromosome 21, with the proximal region of the long arm 21q11.2q22.11 having a log 2 (P/R) of -0.077, the regions 21q22.11 to 21q22.12 with a log 2 ratio of -0.43, and the distal portion 21q22.12qter present in a single copy. Therefore, on the (double) ring chromosome, the centromere through KRTAP11-1 (nucleotides 1-3,239,434; GRCh38) is present in 2 copies, UBE3AP2 through RN7SL740P (nucleotides 32,410,504-35,436,076 ) is present in 1 copy, and MRPSS6 through the telomere (nucleotides 35, 468, 090, 121 
Discussion
We describe a 12-year-old patient with scoliosis and thrombocytopenia who was known to have mosaicism for monosomy 21 and a ring chromosome 21. Features of mosaic monosomy 21 are present in our patient and have been described previously [Cavan et al., 2009] monosomy 21 syndrome, either by mosaicism or partial chromosome loss, presents at birth with phenotypic features including intrauterine growth restriction, low birth weight, cleft lip/palate, facial deformities, microcephaly, and profound intellectual disability [Chettouh et al., 1995; Huret et al., 1995] . Despite the known chromosome anomaly, the explanation for her congenital thrombocytopenia was previously unknown. Microarray analysis demonstrated that a majority of the patient's cells is missing one copy of the RUNX1 gene, leading to the diagnosis of familial platelet disorder (FPD). Although haploinsufficiency of RUNX1 is a mechanism for development of FPD/AML, it is not the most common one. Translocations, small intragenic deletions or duplications, and many point mutations have been described in the literature [Michaud et al., 2002; Béri-Dexheimer et al., 2008; Shinawi et al., 2008; Jongmans et al., 2010; van der Crabben et al., 2010; Buijs et al., 2012; Cavalcante de Andrade Silva et al., 2018] . Patients show various phenotypes ranging from normal to severely affected, depending on the mechanism, and the diagnosis may be missed entirely or even misdiagnosed as Fanconi anemia [Jongmans et al., 2010; Owen, 2010; Click et al., 2011] . The product of RUNX1 is a DNA-binding protein that is part of the core-binding factor transcription complex responsible for hematopoietic stimulation and transcription of proteins related to platelet function (including PRKCQ , MYL9 , and ALOX12 ) [Godley, 2014] . Mutations can occur within the Runt DNA-binding domain or the transactivation domain, where the protein core-binding factor beta binds to increase the complex's affinity for DNA [Godley, 2014] . Mutations in these regions tend to decrease binding affinity at both sites and lead to decreased transcription of target proteins.
The development of hematologic malignancy in carriers of RUNX1 mutations approaches 40%, with an earlier age of onset than sporadic cases [West et al., 2014] . The increased risk begins with a baseline-increased sensitivity of bone marrow progenitor cells to G-CSF stimulation, predisposing patients to increased risk for acquiring secondary mutations [Michaud et al., 2002] . The acquisition of secondary mutations is greatly accelerated in FPD/ AML individuals and is believed to contribute to the increased risk of leukemia transformation. Recent analysis of a patient with FPD/AML has shown that preleukemic cell populations occur in these patients, and multiple mutations are needed before acute leukemia occurs [Ng et al., 2018] . Interestingly, the preleukemic cells may persist after chemotherapy and only disappear after bone marrow transplantation. Patients most commonly acquire a second alteration in RUNX1 within the normal allele that acts as the primary driver of malignancy by a dominantnegative mechanism [Preudhomme et al., 2009] . Other secondary alterations leading to malignancy have also been reported including mutations in NF1 , ASXL1 , CBL , CDC25C , DNMT3A , and KRAS [Godley, 2014] . Although malignant transformation most frequently involves the myeloid lineage including AML and myelodysplastic syndrome, other hematologic malignancies have also been reported, such as T-cell acute lymphocytic leukemia and B cell malignancies [Preudhomme et al., 2009; West et al., 2014] .
In addition to acquired secondary aberrations of the RUNX1 sequence, the congenital RUNX1 mutation has been shown to affect timing and severity of hematologic malignancy development [Owen, 2010] . Deletions, both small and large, have been shown to lead to earlier disease occurrence and may even be associated with more complex phenotypes compared to patients with point mutations. Cases of intellectual disability in conjunction with FPD/AML have been reported and may be due to large deletions of RUNX1 that include adjacent genes associated with neuronal signaling maintenance, such as ITSN1 , RCAN1 , CLIC6 , and SYNJ1 [Béri-Dexheimer et al., 2008; Owen, 2010; van der Crabben et al., 2010] . FPD/AML caused by RUNX1 mutation or deletion is just one of the multiple genes that cause familial predisposition syndromes. ANKRD26 mutations, although less common, also produce a phenotype similar to RUNX1 mutations [Godley, 2014; Swerdlow et al., 2017] . Mutations in genes such as GATA2 and CEPBA show no clinical manifestations other than hematologic malignancy. In addition, bone marrow failure syndromes and telomere disorders can also be associated with increased risk for hematologic malignancy [Godley, 2014; Swerdlow et al., 2017] .
Mechanisms of ring chromosome formation have been well studied, and most studies show that formation occurs with 2 double-strand breaks on a single chromosome with end-joining of the chromosomal fragment containing the centromere. However, it has been found that some ring chromosomes 21 are derived from intermediate isochromosome structures (of the long arms) which then undergo further rearrangement, namely asymmetric breaks and reunion of the long arms [Wong et al., 1989; McGinniss et al., 1992] . A double ring formed in this manner has 2 copies of the sequences nearest the centromere, 1 copy of sequences between the proximal and distal breakpoints, and lacks the distal sequences en- tirely. A recent study of multiple ring chromosomes demonstrated that some rings are formed by a deletion/duplication event, and others may be formed by a multistep process including distal arm deletion and a duplication and inversion event leading to chromosomal instability and ultimately ring formation [Rossi et al., 2008] . The phenotype of the individual carrying such a ring depends on the sequences present on the ring and their copy numbers as well as the level of mosaicism in various tissues and may even include features of Down syndrome.
We demonstrate that the ring chromosome 21 in our case actually is a double ring for the proximal portion of the long arm. Whether the ring was ever a single one cannot be determined from the published karyotype [Cavan et al., 2009] and seems unlikely. The fact that the distal portion of chromosome 21, where the critical region for Down syndrome is located (21q22.13), is present in a single copy in most cells may explain the lack of Down syndrome features [Pelleri et al., 2016] .
Over time, an additional normal cell line with 2 normal chromosomes 21 has arisen. This is likely explained by a reduplication of the monosomic chromosome, which leads to isodisomy (data not shown) for the normal chromosome 21 in a portion of the cells. In addition, a cell with an isochromosome 21 was found, also resulting in a balanced karyotype. These changes likely persist by cell selection for a more balanced genome, although the isochromosome may be a relic of the original isochromosome formation.
In summary, our patient has mosaicism for karyotypically normal cells, a double ring chromosome 21, and monosomy 21 which resulted in haploinsufficiency for RUNX1 and caused FPD/AML. Close follow-up of this patient for her thrombocytopenia, congenital anomalies, and increased risk for AML and other hematologic malignancies is warranted. Geneticists should be aware of the possibility of predisposition to malignancies in patients with certain constitutional abnormalities.
